Clinical trial report: TMC278 (Rilpivirine) versus efavirenz as initial therapy in treatment-Naïve, HIV-1-infected patients

Research output: Contribution to journalArticle

4 Scopus citations
Original languageEnglish (US)
Pages (from-to)1-3
Number of pages3
JournalCurrent Infectious Disease Reports
Volume13
Issue number1
DOIs
StatePublished - Feb 1 2011
Externally publishedYes

ASJC Scopus subject areas

  • Infectious Diseases

Cite this